5-nitro-2-(3-phenylpropylamino)benzoic acid has been researched along with imatinib mesylate in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bauer, S; Breitenbuecher, F; Eilers, G; Ferrera, L; Fletcher, JA; Galietta, L; Grabellus, F; Mühlenberg, T; Schuler, M; Schwindenhammer, B; Simon, S; Taeger, G; Taguchi, T; Treckmann, J | 1 |
1 other study(ies) available for 5-nitro-2-(3-phenylpropylamino)benzoic acid and imatinib mesylate
| Article | Year |
|---|---|
DOG1 regulates growth and IGFBP5 in gastrointestinal stromal tumors.
Topics: Animals; Anoctamin-1; Antineoplastic Agents; Benzamides; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Chloride Channels; Gastrointestinal Stromal Tumors; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Imatinib Mesylate; Insulin-Like Growth Factor Binding Protein 5; Mice; Mice, Inbred Strains; Mice, Nude; Mutation; Neoplasm Proteins; Niflumic Acid; Nitrobenzoates; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Signal Transduction; Xenograft Model Antitumor Assays | 2013 |